Public company info
Input the stock code or the company name     Search  
 


 Stock code   02561 
 Company name  VISEN Pharmaceuticals
 Region  Hong Kong
 Type  MB
 Website  
 Quote  0.0 

Company profile  |  Business review  |  Prospect  |  Latest results  |  Financial ratios
Income statement  |  Cash flow statement  |  Balance sheet  |  Entitlement
Disclosure of interest  |  Quote

 Related stock news
  《大行》大摩對中國生物科技股投資評級...  2026-05-29T  
  《業績》維昇藥業全年虧損擴至2.53...  2026-03-13T  
  《大行》大摩對中資生物醫藥股投資評級...  2026-03-03T  
  維昇藥業隆培生長激素獲生物製品上市許...  2026-01-26T  
  維昇藥業委任首席財務官  2025-10-13T  
  《大行》大摩對生物科技股投資評級及目...  2025-09-22T  
  《大行》大摩：市場對生物科技股認可度...  2025-09-22T  
  《業績》維昇藥業半年虧損擴大至1.1...  2025-08-28T  
  維昇藥業穩定價格期結束 超額配股權失...  2025-04-21T  
  《新股》維昇藥業－Ｂ全日收68.8元  2025-03-21T  
  Search   More 
 Latest News
  南向資金今日淨賣出超106億 港元 ...  2026-08-19T17:  
  ...瑞銀:黃金中期漲勢未完 預計明...  2026-08-19T17:  
  騰訊斥約3億元回購67.3萬股  2026-08-19T  
  《業績》冠君產業信託中期扭虧賺5.4...  2026-08-19T  
  紐約匯市: 美元 隨油價上漲 日元 ...  2026-08-19T05:  
  A50 增強 ETF 富國(5632...  2026-08-19T03:  
  Search   More 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.